dc.contributor.author
Repantis, Dimitris
dc.contributor.author
Bovy, Leonore
dc.contributor.author
Ohla, Kathrin
dc.contributor.author
Kühn, Simone
dc.contributor.author
Dresler, Martin
dc.date.accessioned
2022-09-16T10:51:39Z
dc.date.available
2022-09-16T10:51:39Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/36333
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-36049
dc.description.abstract
Rational: At all times humans have made attempts to improve their cognitive abilities by different means, among others, with the use of stimulants. Widely available stimulants such as caffeine, but also prescription substances such as methylphenidate and modafinil, are being used by healthy individuals to enhance cognitive performance.
Objectives: There is a lack of knowledge on the effects of prescription stimulants when taken by healthy individuals (as compared with patients) and especially on the effects of different substances across different cognitive domains.
Methods: We conducted a pilot study with three arms in which male participants received placebo and one of three stimulants (caffeine, methylphenidate, modafinil) and assessed cognitive performance with a test battery that captures various cognitive domains.
Results: Our study showed some moderate effects of the three stimulants tested. Methylphenidate had positive effects on self-reported fatigue as well as on declarative memory 24 hours after learning; caffeine had a positive effect on sustained attention; there was no significant effect of modafinil in any of the instruments of our test battery. All stimulants were well tolerated, and no trade-off negative effects on other cognitive domains were found.
Conclusions: The few observed significant positive effects of the tested stimulants were domain-specific and of rather low magnitude. The results can inform the use of stimulants for cognitive enhancement purposes as well as direct further research to investigate the effects of stimulants on specific cognitive domains that seem most promising, possibly by using tasks that are more demanding.
en
dc.rights.uri
https://creativecommons.org/licenses/by/4.0/
dc.subject
Neuroenhancement
en
dc.subject
Cognitive enhancement
en
dc.subject
Methylphenidate
en
dc.subject.ddc
600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit::610 Medizin und Gesundheit
dc.title
Cognitive enhancement effects of stimulants: a randomized controlled trial testing methylphenidate, modafinil, and caffeine
dc.type
Wissenschaftlicher Artikel
dcterms.bibliographicCitation.doi
10.1007/s00213-020-05691-w
dcterms.bibliographicCitation.journaltitle
Psychopharmacology
dcterms.bibliographicCitation.originalpublishername
Springer Nature
dcterms.bibliographicCitation.pagestart
441
dcterms.bibliographicCitation.pageend
451
dcterms.bibliographicCitation.volume
238
refubium.affiliation
Charité - Universitätsmedizin Berlin
refubium.funding
Springer Nature DEAL
refubium.resourceType.isindependentpub
no
dcterms.accessRights.openaire
open access
dcterms.bibliographicCitation.pmid
33201262
dcterms.isPartOf.issn
0033-3158
dcterms.isPartOf.eissn
1432-2072